Garry Nolan - Dec 9, 2021 Form 4 Insider Report for Akoya Biosciences, Inc. (AKYA)

Role
Director
Signature
/s/ Garry Nolan, by Brian McKelligon, as Attorney-in-Fact
Stock symbol
AKYA
Transactions as of
Dec 9, 2021
Transactions value $
-$316,763
Form type
4
Date filed
12/13/2021, 05:06 PM
Previous filing
May 25, 2021
Next filing
Dec 15, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKYA Common Stock Sale -$317K -25K -3.68% $12.67 655K Dec 9, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Column 4 reflects a weighted average price. Shares sold in multiple transactions at prices ranging from $12.59-$12.74. Reporting person undertakes to provide issuer, securityholder of issuer or SEC staff, upon request, information regarding number of shares sold at each separate price within ranges set forth herein.